Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 35 citing articles:

Beneficial Bacteria Isolated from Food in Relation to the Next Generation of Probiotics
Barbara Sionek, Aleksandra Szydłowska, Dorota Zielińska, et al.
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1714-1714
Open Access | Times Cited: 26
Neuroinflammation and Schizophrenia: New Therapeutic Strategies through Psychobiotics, Nanotechnology, and Artificial Intelligence (AI)
Freiser Eceomo Cruz Mosquera, Maria Camila Guevara-Montoya, Valentina Serna-Ramirez, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 391-391
Open Access | Times Cited: 15
Exploring the gut-brain Axis: Potential therapeutic impact of Psychobiotics on mental health
Ana- Maria Cocean, Dan Cristian Vodnar
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 134, pp. 111073-111073
Open Access | Times Cited: 10
Review of the Potential of Probiotics in Disease Treatment: Mechanisms, Engineering, and Applications
Mingkang Liu, Jinjin Chen, Ida Putu Wiweka Dharmasiddhi, et al.
Processes (2024) Vol. 12, Iss. 2, pp. 316-316
Open Access | Times Cited: 8
Human Gut Microbiota for Diagnosis and Treatment of Depression
Olga V. Averina, Е. У. Полуэктова, Yana Zorkina, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5782-5782
Open Access | Times Cited: 8
Impact of Probiotic Supplementation and High-Intensity Interval Training on Primary Dysmenorrhea: A Double-Blind, Randomized Controlled Trial Investigating Inflammation and Hormonal Modulation
Minsheng Yang, Hao Yu Chen, Chi-Hong Ho, et al.
Nutrients (2025) Vol. 17, Iss. 4, pp. 622-622
Open Access | Times Cited: 1
Psychobiotics for Mitigation of Neuro‐Degenerative Diseases: Recent Advancements
Priya Dhyani, Chhaya Goyal, Sanju Bala Dhull, et al.
Molecular Nutrition & Food Research (2023) Vol. 68, Iss. 13
Open Access | Times Cited: 13
A Narrative Review on Gut Microbiome Disturbances and Microbial Preparations in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Long COVID
Joanna Michalina Jurek, Jesús Castro‐Marrero
Nutrients (2024) Vol. 16, Iss. 11, pp. 1545-1545
Open Access | Times Cited: 5
The Potential of Probiotics in Disease Treatment: Mechanisms, Engineering, and Applications
Mingkang Liu, Jinjin Chen, Ida Putu Wiweka Dharmasiddhi, et al.
(2024)
Open Access | Times Cited: 4
Evaluating the scientific evidence to support mental health and well-being claims made on probiotic products
Rebecca F. Slykerman, Naomi Davies, Robert Donohoe
Nutrition and Health (2025)
Closed Access
Psychobiotic Protection of Nutritional Supplements and Probiotics in Patients Undergoing Hemodialysis: A Randomized Trial
Eric Climent, Francisco Hevilla, Marina Padial, et al.
Nutrients (2025) Vol. 17, Iss. 4, pp. 652-652
Open Access
Beyond the pandemic: physical activity and health behaviors as predictors of well-being among Filipino tertiary students
Lizamarie Campoamor-Olegario, Desiderio S. Camitan, Maria Luisa M. Guinto
Frontiers in Psychology (2025) Vol. 16
Open Access
ПРОБІОТИКИ ЯК АЛЬТЕРНАТИВНІ АНТИМІКРОБНІ ЗАСОБИ
Mykola Spivak, Л. А. Сафронова
Інфекційні хвороби (2025), Iss. 1, pp. 4-8
Closed Access
Les psychobiotiques, une révolution thérapeutique en devenir
Laura Obry, Guylène Page
Actualités Pharmaceutiques (2025) Vol. 64, Iss. 645, pp. 16-20
Closed Access
Intestinal dysbiosis leads to the reduction in neurochemical production in Parkinson’s disease (PD)
Rahul Kumar, Rahul Kumar
International review of neurobiology (2025)
Closed Access
Psikobiyotikler ve Ruhsal Hastalıklar: Bir Gözden Geçirme
Merve ÖZ
İstanbul Gelişim Üniversitesi Sosyal Bilimler Dergisi (2025) Vol. 12, Iss. 1, pp. 402-414
Open Access
The gut microbiome in post-COVID syndrome patients
Yali Zhai, Xiaokang Li, Jiahai Lu, et al.
The Innovation Medicine (2025), pp. 100123-100123
Closed Access
Probiotics as technological innovations in psychiatric disorders: patents and research reviews
Alyne Almeida de Lima, Sthefane Silva Santos, Maria Ilma Araújo, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
The Impact of Early-Life Cecal Microbiota Transplantation on Social Stress and Injurious Behaviors in Egg-Laying Chickens
Yuechi Fu, Jiaying Hu, Huanmin Zhang, et al.
Microorganisms (2024) Vol. 12, Iss. 3, pp. 471-471
Open Access | Times Cited: 3
A Narrative Review of Intestinal Microbiota’s Impact on Migraine with Psychopathologies
Miriam Francavilla, Sara Facchetti, Chiara Demartini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6655-6655
Open Access | Times Cited: 3
Is Nasal Dysbiosis a Required Component for Neuroinflammation in Major Depressive Disorder?
Jorge Manuel Vásquez-Pérez, Edith González‐Guevara, Diana Gutiérrez-Buenabad, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 3
A Narrative Review on Gut Microbiome Disturbances and Microbial Preparations in ME/CFS: Implications for Long COVID
Joanna Michalina Jurek, Jesús Castro‐Marrero
(2024)
Open Access | Times Cited: 2
The role of nutrition in mild traumatic brain injury rehabilitation for service members and veterans
Katrina Monti, MAJ William Conkright, Shawn R. Eagle, et al.
Neurorehabilitation (2024) Vol. 55, Iss. 3, pp. 281-294
Closed Access | Times Cited: 2
Gut dysbiosis mediates the association between antibiotic exposure and chronic disease
Francisco Guarner, L Bustos Fernandez, Sylvia Cruchet, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Resolving a paradox: antidepressants, neuroinflammation, and neurodegeneration
Ravi Philip Rajkumar
Exploration of Neuroprotective Therapy (2024), pp. 11-37
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top